Central TB team reviews implementation of programmes in district
The team commended the district and medical officers for their efforts in raising awareness about the prevention and control of tuberculosis.
They visited the APIIC Colony Urban Primary Health Centre and reviewed the implementation of the Central programme. At the clinic they inquired about the awareness programmes being held, diagnosis of the disease, free medicines being given to patients, and preventive measures being taken to reduce contracting the disease.
Later, they visited the TB lab at Siddhartha Medical College and inquired about the services there. The medical officers briefed them on the medical examinations conducted, treatment given, and nutritional food provided to patients through the Nikshay Poshan Yojana scheme.
Officials added that steps are being taken to identify tuberculosis patients through village-level outreach. The diagnosed are being put on immediate treatment and provided with nutritional food.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
39 minutes ago
- The Hindu
Tezpur University team develops low-cost device to detect tuberculosis
GUWAHATI A team of researchers from central Assam's Tezpur University has developed an affordable and portable device to detect tuberculosis (TB). The researchers said the device, using the autofluorescence or natural glow of the TB bacteria for detection instead of any chemical or dye, has been specially designed for use in rural and remote areas where advanced medical facilities are not easily available. Pabitra Nath of the university's Department of Physics and the team leader, said the device has a built-in heating system to improve test accuracy and can be operated using a smartphone. 'It costs under ₹25,000 and weighs less than 300 grams, making it a perfect fit for places with limited healthcare infrastructure,' he said. The other members of the team are Biprav Chetry and Chunuranjan Dutta, research scholars from Tezpur University's Department of Physics; J.P. Saikia and Santanu Goswami from the Department of Molecular Biology and Biotechnology; and Abhijit Gogoi from Labdig Innovations and Systems Private Limited. Early and accurate diagnosis is crucial in stopping the spread of TB, a major public health issue in India. The World Health Organization (WHO) and India's National TB Elimination Programme currently recommend LED fluorescence microscopy as the gold standard for TB screening. However, the standard testing method recommended by the WHO needs expensive machines and trained technicians, which are not available in many rural areas. The new device can solve this problem by making TB testing simpler and more accessible, the researchers said. 'While LED-FM offers higher sensitivity than conventional optical microscopy, it has several drawbacks. It depends on costly equipment, chemical staining agents like auramine-O, and trained personnel for sample preparation and interpretation. Furthermore, its reliance on laboratory infrastructure makes it impractical in many rural settings,' Professor Nath said. The device developed by the Tezpur University researchers leverages the principle of autofluorescence, a natural property of certain microbial cells, including Mycobacterium tuberculosis (mTB) cells, that emit a fluorescence signal when excited by a specific wavelength of light. 'The team's key innovation lies in the integration of a heating element within the sensor system. By raising the temperature of the bacterial sample, the system enhances the natural fluorescence signal from mTB cells, enabling trace-level detection without the use of stains or dyes,' Prof. Nath explained. The team has filed a patent for the device, and their study was published in Biosensors and Bioelectronics, an international journal.
Time of India
18 hours ago
- Time of India
AI-assisted diagnostic drive starts to make Nagpur TB-free
1 2 Nagpur: Indira Gandhi Govt Medical College and Hospital (IGGMC), with support from chief minister Devendra Fadnavis, launched a pilot project — NIIDAN-TB (Nagpur-IGGMC Initiative for Diagnosis, Active Case-Finding, and Notification of TB) — for the elimination of the disease in line with the national mission. As per the city TB office, Nagpur currently has 4,075 notified cases, with 3,625 of them under treatment. A total of 71 TB patients have died this year so far. The mortality and cases seem to have come down in the last few years, and the IGGMC has undertaken the massive exercise to make Nagpur TB-free. This project aims to combat tuberculosis (TB) through advanced diagnostics, active case-finding, and preventive measures, targeting 1,00,000 high-risk individuals, with an initial focus on 25,000 presumptive TB cases across five tuberculosis units (TUs). The five TUs are at IGGMCH, NMC's Indira Gandhi Rugnalaya, Govt Ayurvedic College, GMCH, and Mahal. These units cover 25 urban primary health centres in Nagpur, including Hudkeshwar, Manewada, and Mominpura. The initiative integrates cutting-edge technology with rigorous field interventions. A mobile TB van equipped with AI-assisted chest X-ray technology enables rapid on-site screening in high-risk areas. An advanced mycobacteriology laboratory at IGGMC's microbiology department facilitates molecular diagnostics, testing sputum for TB and resistance to first-line drugs like isoniazid and rifampicin. Door-to-door screening by field coordinators, supported by ASHA workers, will identify presumptive cases using a symptom-based questionnaire focusing on cough lasting over two weeks, hemoptysis, fever, and weight loss. High-risk groups, including diabetics, the elderly, PL-HIV, alcoholics, smokers, TB contacts, and slum residents, are prioritised. Presumptive cases will undergo chest X-rays in the mobile van, with AI providing immediate results to guide further testing. Sputum samples from positive or suspicious cases are sent to IGGMC's NAAT lab for advanced diagnostics. Confirmed TB patients will be linked to nearby health centres, registered on the Nikshay app, and provided free treatment under the National TB Elimination Programme (NTEP). They will also receive ₹1,000 monthly via Nikshay Poshan Yojana for nutritional support, alongside counselling on treatment adherence, infection control, and stigma reduction. The project will screen household contacts for latent TB infection (LTBI) using the Cy-TB test, offering TB preventive therapy (TPT) to prevent future disease. Under the guidance of Dr Ravi Chauhan, dean, IGGMC, the supervising team is led by Dr Radha Munje, professor and head, department of respiratory medicine, IGGMC Nagpur. Core team members include Dr Gopal Agrawal, Dr Gyanshankar Mishra, Dr Dilip Gedam, Dr Sanjeev Chaudhary, Dr Sagar Pande, Dr Bhavana Sonavne, and Dr Sadaf Khateeb. Honorary members supporting the project include Dr Deepak Selokar, medical health officer, Nagpur Municipal Corporation (NMC), and Dr Shilpa Jichkar, city TB officer, Nagpur. The mobile TB unit was flagged off during the inauguration, attended by MLA Pravin Datke, MLA Dr Ashish Deshmukh, and collector Vipin Itankar. The public is urged to cooperate, especially those with TB symptoms, to help Nagpur achieve India's goal of TB elimination.
Time of India
20 hours ago
- Time of India
Prolonged use of ethambutol leads to vision loss in TB patients, says study by doctors of LV Prasad Eye Institute
Hyderabad: A recent study conducted by the doctors at the LV Prasad Eye Institute (LVPEI) raised concerns about severe vision loss caused by ethambutol, a drug commonly used to treat tuberculosis (TB). Published in the Indian Journal of Ophthalmology, the study reveals that prolonged use of ethambutol, which is used as part of India's TB treatment programme due to its relatively low toxicity, combined with higher dosages, is linked to a sharp rise in cases of ethambutol-induced toxic optic neuropathy (ETON). It is a condition that damages the optic nerve and impacts vision. The study also pointed out that the Central govt's National TB Elimination Programme (NTEP), which is implemented across the country, including in Telangana, uses ethambutol extensively. In 2016, the NTEP extended the use of ethambutol from two to six months and also increased the dosage frequency to once daily from thrice a week. Since then, the ETON cases increased sixfold within three years. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad During the research, the LVPEI doctors examined 107 patients suffering from ETON, with around 58% of them being middle-aged (36 to 55 years), who took the drug for seven consecutive months. Doctors found that almost all of the patients experienced severe vision loss in both eyes, with the elderly (above 60 years) being the worst affected, despite the low toxicity levels of the drug. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Your IQ Is 140 If You Can Answer 10 of These Questions Correctly. IQ International Undo However, after they discontinued ethambutol, an 11-month follow-up found that the vision clarity of the patients started improving, except for the elderly. 'ETON has become more common and can lead to severe vision loss, especially in the elderly, individuals with low body weight, and those with kidney problems (renal dysfunction). Symptomps include change in vision, contrast or colour vision. There are smartphone-based apps which the patients can use to check vision and colour vision at home. Dosage should be recommended as per body weight, age and kidney function. Careful monitoring and early discontinuation of the drug are essential to prevent vision loss,' said Dr Virender Sachdeva, one of the authors. In March this year, the World Health Organisation (WHO) pointed out that while India showed significant progress in reducing TB cases and improved treatment coverage, it is unlikely to meet the 2025 target set by the WHO's 'End TB Strategy'. WHO's Global Tuberculosis Report 2024 stated that India had 26% of global TB cases and 26% of global deaths in 2023, the highest in the world. According to officials in the Telangana health, family, and welfare dept, currently around 81 lakh people of the over 3.5 crore population (20%) in Telangana are TB-prone, with 10 lakh alone in Hyderabad. Official numbers tabled in Parliament showed that Telangana recorded 1.37 lakh TB cases and 2,663 deaths from July 2023 to Dec 2024. Noting that the findings of the study will be reviewed, senior officials of the TB programme, health dept, said, 'After completing the 100-day action plan, we again launched a continuous plan in June this year to boost TB screening, awareness, and care in Hyderabad, rural areas, and urban slums. Special emphasis is being given to people above 60 years, those who drink and smoke, previous TB patients, family members of the present TB patients, and people with comorbidities. '
